Tissue Diagnostics Market Competitive Landscape

1. Tissue Diagnostics Market Worth $8.52 Billion by 2029

2. Tissue Diagnostic Market worth $8.52 Billion by 2029 Meticulous Research®—a leading global market research company, published a research report titled, ‘Tissue Diagnostics Market by Product Type (Antibodies, Kits, Reagents, Instruments [Slide Stainer, Scanner]), Technique (Digital Pathology, IHC, ISH, H&E Staining), Cancer Type (Breast, NSCLC, Colorectal, Prostate), End user—Global Forecast to 2029’. According to this latest publication from Meticulous Research, the global tissue diagnostics market is projected to reach $8.52 billion by 2029, at a CAGR of 7.4%. The rising prevalence of cancer globally, the availability of biomarkers and research on biomarkers, recommendations for cancer screening, the growing number of clinical trials for oncology drugs, and the availability of tissue- based companion diagnostics are the factors driving the growth of this market. To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/tissue-diagnostics-market-4971 Tissue Diagnostics Market: Future Outlook The global tissue diagnostics market is segmented by Product Type (Consumables [Kits & Reagents, Antibodies], Instruments [Slide Staining Systems, Tissue Microarrays, Slide Scanners, Tissue Processors, Other Instruments {Embedding Systems, PCR, NGS]); Technique (Immunohistochemistry, In-situ Hybridization, Digital Pathology, H&E and Special Staining, Molecular Diagnostics, Other Techniques); Application (Breast Cancer, Lung Cancer, Colorectal and Gastrointestinal Cancer, Prostate Cancer, Lymphoma, Other Applications); End User (Hospitals & Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, and Contract Research Organizations). The study also evaluates industry competitors and analyzes their market shares at the global and regional levels. Based on product, in 2022, the consumables segment is expected to account for the largest share of the market. The extensive and recurring requirement of consumables and technological advances in developing novel reagents contribute to the large market share of this segment. Page 1 of 3 © Meticulous Research| sales@meticulousresearch.com

3. Tissue Diagnostic Market worth $8.52 Billion by 2029 Based on technique, the tissue diagnostics market is segmented into immunohistochemistry, in-situ hybridization, digital pathology, H&E and special staining, molecular diagnostics, and other techniques. In 2022, the immunohistochemistry segment is expected to account for the largest share of the global tissue diagnostics market. Developments in in-vitro diagnostics and the upsurge in point-of-care diagnostics are the factors contributing to the growth of this segment. Access Our Report Here: https://www.meticulousresearch.com/download-sample- report/cp_id=4971 Based on application, the tissue diagnostics market is segmented into breast cancer, lung cancer, colorectal & gastrointestinal cancer, prostate cancer, lymphoma, and other applications. In 2022, the breast cancer segment is expected to account for the largest share of the global tissue diagnostics market. The growth of this segment is attributed to the high prevalence of breast cancer and the presence of several research and screening programs for combating breast cancer. Based on end user, in 2022, the hospitals & diagnostic laboratories segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the high inflow of patients and tests due to the increasing prevalence of cancer. This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America, and the Middle East & Africa. In 2022, North America is expected to account for the largest share of the tissue diagnostics market. The large market share of this regional market is driven by the high cancer prevalence, easy accessibility to advanced technologies, and the presence of public programs for cancer management. Request Sample Report:https://www.meticulousresearch.com/request-sample- report/cp_id=4971 Key Players: The key players operating in the global tissue diagnostics market are F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Abbott Laboratories (U.S.), Danaher Corporation (U.S.), QIAGEN N.V. (Netherlands), Becton, Dickinson and Company (U.S.), Abcam plc (U.K.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), Sakura Finetek Japan Co., Ltd. (Japan), Cell Signaling Technology, Inc. (U.S.), Bio-Genex Laboratories (U.S.), Bio SB, INC (U.S.), 3DHISTECH (Hungary), and HOLOGIC, INC. (U.S.). Key questions answered in the report- •Which are the high-growth market segments in terms of product type, technique, application, end user, and regions/countries? •What was the historical market for tissue diagnostics across the globe? •What are the market forecasts and estimates for the period 2022–2029? •What are the major drivers, restraints, challenges, opportunities, and trends in the global tissue diagnostics market? Page 2 of 3 © Meticulous Research| sales@meticulousresearch.com

4. Tissue Diagnostic Market worth $8.52 Billion by 2029 •Who are the major players in the global tissue diagnostics market? •How is the competitive landscape, and who are the market leaders in the global tissue diagnostics market? •What are the recent developments in the tissue diagnostics market? •What are the different strategies adopted by the major players in the tissue diagnostics market? •What are the geographical trends and high-growth regions/countries? Customize my Report:https://www.meticulousresearch.com/request- customization/cp_id=4971 Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 3 of 3 © Meticulous Research| sales@meticulousresearch.com